Document:

a6545259ex10_27.htm

Exhibit 10.27

December 8, 2010

Mr. Drew A. Moyer

Via Hand Delivery

Dear Drew:

This letter amends and restates your Employment Agreement dated July 23, 2008 and serves as an agreement between you and Pulse Electronics Corporation (“Pulse”) regarding what constitutes a termination of your employment at Pulse and setting forth the rights and obligations of each of us upon the occurrence of such a termination.  We intend that this letter constitutes a legal and binding agreement between us, and we acknowledge good and valuable consideration for our joint promises in this letter.  The letter agreement dated July 31, 2010 regarding your service as Interim President and Interim Chief Executive Officer (“Interim Service Agreement”) remains in full force and is not affected by this letter.  The Compensation Committee of the Board of Directors of Pulse (the “Board”) approved this Agreement at a meeting on December 8, 2010, and it shall have a term which expires on July 23, 2012.

	
1.

	
Definitions.

“Agreement” means this letter between Pulse and Drew A. Moyer dated December 8, 2010.

 

“Cause” means any of the following: (a) the occurrence of gross negligence or willful misconduct which is materially injurious to Pulse and which, if susceptible of cure, is not cured within thirty (30) days after notice to you which cites with reasonable particularity the  actions or omissions believed to constitute such gross negligence or willful misconduct; (b) conviction of or the entry of a pleading of guilty or nolo contendere to any felony, unless the Board concludes in good faith that such event does not render you unable to effectively perform your duties as Chief Financial Officer or materially and adversely affect Pulse’s reputation or ongoing business activities; or (c) misappropriation of Pulse’s funds or other dishonesty which in the good faith opinion of the Board, renders you unable to effectively manage Pulse or materially and adversely affects Pulse’s reputation or ongoing business activities.

“Company Car Transition Plan” means that at the end of the current lease to your company car (a) Pulse will deliver title of the leased car to you and provide you with a one-time equity award of $50,000 and a special salary increase of 5% of your then current base salary, and (b) you will no longer be provided with a company car.

 

  

1

  

	
  

	
“Disability”  shall mean that you are unable, by reason of mental or physical incapacity or illness, to substantially perform your duties to Pulse for a period of either 90 consecutive days or an aggregate of 120 days in any 12-month period, as determined by Pulse in good faith and in its sole discretion.

 “Good Reason” means:

 

a)   a material change in your authority, duties or responsibilities, other than an end to your Interim Service Agreement, or

 

b)   the failure of Pulse or the Board to act in good faith with respect to this Agreement or the failure to perform its material obligations under this Agreement which have not been cured within twenty (20) days after written notice from you setting forth the acts or omissions alleged to constitute such a failure with reasonable particularity, or

 

c)   any actual reduction in your annual base salary (for purposes of this Agreement a failure to raise your base salary in any period and the Company Car Transition Plan shall not be considered to be a reduction in your base salary and the special salary supplement provided by your Interim Service Agreement shall not be considered part of your base salary) or

 

d)   Pulse requiring you to be based at any office or location which is located more than 25 miles from Trevose, PA, or

 

e)   except as provided in your Interim Service Agreement, failure to be included in any benefit plan in which all other senior Pulse similarly situated executives participate.

 

“Sec. 409A” means Section 409A of the Internal Revenue Code of 1986, as amended, and the rules and regulations promulgated thereunder.

2.           Employment Termination .

Your employment with Pulse shall terminate upon the earlier occurrence of any of the following events to be effective from and after the date of such event:

A.   your death or retirement;

B.   you become totally disabled;

C.   Pulse terminates your employment for Cause ;

D.   Pulse terminates your employment for any reason other than Cause;

E.   You terminate your employment for Good Reason; or

 

  

2

  

F.   You terminate your employment for any reason other than Good Reason

3.           Effect of Employment Termination.

(i)           Death or Retirement:  Upon termination of your employment due to your death, or your voluntary retirement after the age of  62, then, Pulse will pay you or your estate a sum equal to:

 

a.           The unpaid portion of your base salary through the end of the month in which termination occurs;

b.           any bonus (commensurate with those paid to other executives) for the bonus period in which termination occurs, pro-rated to the date of termination; and

c.           any other ordinary course benefits to which you were entitled as an employee of Pulse and/or pursuant to a cash or stock- based incentive or bonus plan, or other benefit, retirement or other plan, program or arrangement which were then due but unpaid at the date of your death, including reimbursement for expenses not yet paid and incurred in accordance with Pulse’s policy.

	
  

	
d.

	
All of the benefits referred to in this Section 3(i) will be paid no later than thirty (30) days after the date of your death or retirement, except those provided under any successor plan(s) to the Technitrol, Inc. Supplemental Executive Retirement Plan which shall be provided for in accordance with the terms of such plan(s).

	
  

	
(ii)       Disability:  Upon termination of your employment due to your Disability, then (in addition to providing to you the benefits due under any  disability, retirement or other benefit plan),  Pulse will pay you a sum 

equal to:

  

a. the unpaid portion of your base salary through the end of the month in which termination is determined to have occurred;

b.   any bonus (commensurate with those paid to other executives) or the bonus period in which termination is determined to have occurred, pro rated to the date of termination; and

c.    any other ordinary course benefits to which you were entitled as an employee of Pulse and/or pursuant to a cash or stock-based incentive or bonus plan, or other benefit, retirement or other plan,  program or arrangement which were then due but unpaid at the date of your Disability, including reimbursement for expenses not yet paid and incurred in accordance with Pulse’s policy.

 

  

3

  

	
  

	
d.

	
The benefits set forth in subsection (ii) above will be paid no later than thirty (30) days after the date on which your Disability is deemed to commence.

(iii)      By Pulse for Cause or by You Without Good Reason: 

Upon employment termination by Pulse for Cause or by you without Good Reason, Pulse will pay you, within thirty (30) days after the date of your termination, a sum equal to:

a.           The unpaid portion of your base salary through the effective date of termination; and

b           any other ordinary course benefits to which you were entitled as an employee of Pulse and/or pursuant to a cash or stock-based  incentive or bonus plan, or other benefit, retirement or other plan, program or  arrangement which were then due but unpaid at the date of  termination, including reimbursement for expenses not yet paid and incurred in accordance with Pulse’s policy.

(iv)           By Pulse Without Cause or by You for Good Reason:

Upon termination of your employment by Pulse without Cause or by you for Good Reason, Pulse will:

a.             Pay you the unpaid portion of your base salary through the end of the month in which termination occurs;

	
  

	
b.

	
Pay you an amount equal to 2.625 times your annual salary in effect at the date of termination;

	
  

	
c.

	
Pay you any other ordinary course benefits to which you were entitled as an employee of Pulse and/or pursuant to a cash or stock-based incentive or bonus plan, or other benefit, retirement or other plan, program or arrangement which were then due but unpaid at the date of termination, including reimbursement for expenses not yet paid which were incurred in accordance with Pulse’s policy;

d.            Immediately vest any shares of restricted stock which are held by you on the date of such termination and which have not yet vested and pay you any related cash or tax gross-up payments provided for by any applicable plan and immediately vest any stock options which are held by you on the date of such termination and which have not yet vested.

 

  

4

  

	
  

	
e.

	
Provide you with health and life insurance benefits as you were receiving them on the date of termination along with your health club membership, in each case for 18 months following the date of termination.  Pulse will continue to pay these expenses on your behalf when due for the period indicated in the preceding sentence.  However, if it is necessary, in the opinion of counsel, to ensure that this Agreement is in compliance with Section 409A, you may pay any or all of these expenses when due until the date that is six months after the date of your termination of employment and Pulse will reimburse you for such expenses that you have paid on the date which is six months after your termination date.

	
  

	
f.

	
Provide you with outplacement services from an agency of your choice reasonably satisfactory to Pulse. Pulse will pay the reasonable expenses of such a service for a period not to exceed 12 months from commencement of such services.

	
  

	
g.

	
Deliver title of the car to you and provide you with the equity award under the Company Car Transition Plan, to the extent such plan provisions have not already been completed.

All of the benefits referred to in this section (iv) above will be paid no later than thirty (30) days after the date of your  termination, or, if necessary, in the opinion of counsel, to ensure that this Agreement is in compliance with Sec. 409A, on the date that is six months after your termination of employment.

4.           Capacity and Duties.

You shall devote your full working time, energy, skill and best efforts to the performance of your duties set forth in this Agreement, in a manner which will faithfully and diligently further the business and interests of Pulse and its subsidiaries, and shall not be employed by, or participate or engage in, or be a part of in any manner, including as an employee, consultant, director, trustee or similar function  (with the exception of (1) the Philadelphia Zoo, and (2) a business operated by a member of your immediate family in which your involvement does not materially interfere with your ability to perform your duties for Pulse in a good, workmanlike and timely manner), the management or operation of any other enterprise without the prior written consent of the Board, which consent may be granted or withheld in its sole discretion.

5.           Confidentiality.

You acknowledge a duty of confidentiality owed to Pulse and shall not, at any time during your employment by Pulse or thereafter, use, divulge, furnish, or make accessible to anyone, without the express authorization of the Board, any trade secret, private or confidential information of Pulse or any of its subsidiaries obtained or acquired while so employed.  All computer software, customer lists, price lists, catalogs, records, and proprietary know-how acquired while an employee of Pulse, are acknowledged to be the property of Pulse and shall not be duplicated, removed from Pulse’s possession, or made use of other than in pursuit of Pulse’s business; and, upon termination of employment for any reason, you shall promptly deliver to Pulse, without further demand, all copies thereof which are then in your possession or control.

 

  

5

  

6.           Inventions and Improvements.

During the term of your employment, you shall promptly communicate to Pulse all ideas, discoveries and inventions which are or may be useful to Pulse or its business.   You acknowledge that all ideas, discoveries, inventions, and improvements which are made, conceived, or reduced to practice by you and every item of knowledge relating to Pulse’s business interests (including potential business interests) gained by you during your employment are the property of Pulse, and you irrevocably assign all such ideas, discoveries, inventions, improvements, and knowledge to Pulse for its sole use and benefit, without additional compensation. The provisions of this Section shall apply whether such ideas, discoveries, inventions, improvements or knowledge are conceived, made or gained by you alone or with others, whether during or after usual working hours, whether on or off the job, whether applicable to matters directly or indirectly related to Pulse’s business interests (including potential business interests), and whether or not within the specific realm of your duties. You shall, upon the request of Pulse, at any time during or after your employment with Pulse, sign all instruments and documents requested by Pulse and otherwise cooperate with Pulse to protect its right to such ideas, discoveries, inventions, improvements, and knowledge, including applying for, obtaining, and enforcing patents and copyrights thereon.

7.           Noncompetition.

During the term of your employment and for 18 months after any termination of employment, you shall not directly or indirectly:

a.           engage, directly or indirectly, anywhere in the world, in the manufacture, assembly, design, distribution or marketing of any product or equipment substantially similar to or in competition with any product or equipment which at any time during the term of such employment or the immediately preceding twelve month period has been manufactured, sold or distributed by Pulse or any subsidiary or any product or equipment which Pulse or any subsidiary was developing during such period for future manufacture, sale or distribution;

b.           be or become a stockholder, partner, owner, officer, director or employee or agent of, or a consultant to or give financial or other assistance to, any person or entity considering engaging in any such activities or so engaged;

 

  

6

  

	
  

	
c.

	
seek in competition with the business of Pulse to procure orders from or do business with any customer of Pulse;

	
  

	
d.

	
solicit, or contact with a view to the engagement or employment by, any person or entity of any person who is an employee of Pulse;

	
  

	
e.

	
seek to contract with or engage (in such a way as to adversely affect or interfere with the business of Pulse) any person or entity who has been contracted with or engaged to manufacture, assemble, supply or deliver products, goods, materials or services to Pulse; or

	
  

	
f.

	
engage in or participate in any effort or act to induce any of the customers, associates, consultants, or employees of Pulse or any of its affiliates to take any action which might be disadvantageous to Pulse or any of its affiliates; except that nothing in this Agreement shall prohibit you from owning, as a passive investor, in the aggregate not more than 5% of the outstanding publicly traded stock of any corporation so engaged.  The duration of your covenants set forth in this Section shall be extended by a period of time equal to the number of days, if any, during which you are in violation of the provisions contained in this Agreement.

8.           Injunctive and Other Relief.

You acknowledge that the covenants contained in this Agreement are fair and reasonable in light of the consideration paid under this Agreement, and that damages alone shall not be an adequate remedy for any breach by you of such covenants, and accordingly expressly agree that, in addition to any other remedies which Pulse may have, Pulse shall be entitled to injunctive relief in any court of competent jurisdiction for any breach of any such covenants by you.  Nothing contained in this Agreement shall prevent or delay Pulse from seeking, in any court of competent jurisdiction, specific performance or other equitable remedies in the event of any breach by you of any of your obligations under this Agreement.

Monetary claims against you under this Agreement will in no event exceed the amount actually paid to you under this Agreement.

9.           Mitigation

You shall not be required to mitigate damages or the amount of any payment provided for under this Agreement by seeking other employment or otherwise, and compensation earned from such employment or otherwise shall not reduce the amounts otherwise payable under this Agreement.  No amounts payable under this Agreement shall be subject to reduction or offset in respect of any claims which Pulse (or any other person or entity) may have against you.

 

  

7

  

10.           Employment Status

You and Pulse acknowledge and agree that your employment is “at will” and may be terminated at any time, by Pulse with or without Cause or by you with or without Good Reason, subject to applicable law.

11.           Miscellaneous Provisions

	
  

	
A.

	
Neither you nor Pulse will assign this Agreement without the prior written consent of the other.  This Agreement will bind any successors to Pulse.

	
  

	
B.

	
Each notice, request, demand, approval or other communication which may be or is required to be given under this Agreement shall be in writing and shall be deemed to have been properly given when delivered personally at the address set forth below for the intended party during normal business hours at such address, when sent by facsimile or other electronic transmission to the respective facsimile transmission numbers of the parties set forth below with telephone confirmation of receipt, or when sent by recognized overnight courier or by the United States registered or certified mail, return receipt requested, postage prepaid, addressed as follows:

 

	  	
If to Pulse:

	
Pulse Electronics Corporation

	  	  	
1210 Northbrook Drive

	  	  	
Suite 470

	  	  	
Trevose, PA  19053

	  	  	
Attn: Lead Director

	  	  	  
	  	
If to you:

	
Drew A. Moyer

	  	  	
To your residential address as listed in Pulse's Human Resources records.

 

	
  

	
C.

	
This Agreement is the entire agreement between us regarding the subject matter to which it relates and supersedes all prior agreements and understandings, oral or written.  This Agreement cannot be amended, changed or modified except in a writing signed by both parties.

	
  

	
D.

	
This Agreement will be governed and construed in accordance with Pennsylvania law.

  

8

  

	
  

	
E.

	
The invalidity or unenforceability of any particular provision or part of any provision of this Agreement shall not affect the other provisions or parts of this Agreement.  If any provision of this Agreement is determined to be invalid or unenforceable by a court of competent jurisdiction, such provision shall be interpreted to provide protection as nearly equivalent to that found to be invalid or unenforceable and if any such provision shall be so determined to be invalid or unenforceable by reason of the duration or geographical scope of the covenants contained in this Agreement, such duration or geographical scope, or both, shall be considered to be reduced to a duration or geographical scope to the extent necessary to cure such invalidity.

	
  

	
F.

	
Any indemnification obligations of Pulse to which you are entitled as a director, officer and employee of Pulse, whether by contract or pursuant to Pulse’s charter or by-laws, relating to the period prior to termination, shall survive such termination and shall thereafter be paid to you as and when due in accordance with applicable law and the constituent documents of Pulse.

	
  

	
G.

	
The obligations of Pulse under this Agreement (together with Pulse’s obligations to you under a cash or stock-based incentive or bonus plan or other benefit, retirement or other plan, program or arrangement), shall be in lieu of any other damages, compensation or benefits to which you might be entitled, directly or indirectly, in connection with this Agreement.

	
  

	
H.

	
The payments due to you under this Agreement are conditioned upon the execution and delivery by you, and/or your personal representatives, of a general release, pursuant to which you shall release Pulse from all claims relating to your employment or otherwise, except Pulse’s continuing obligations under this Agreement; provided that such release shall not obligate you to perform any services for Pulse during any period after your employment nor correlate any benefits to which you are entitled on “transition period” cooperation.

  

9

  

If the foregoing meets with your approval, please sign where indicated below and return a signed copy to me.

 

 

	  	  	  
	  	
Sincerely,

	  
	  	  	  
	  	
PULSE ELECTRONICS CORPORATION

	  
	  	  	  
	  	  	  
	  	  	  
	  	
 /s/ John E. Burrows, Jr.

	  
	  	
By:  John E. Burrows, Jr.

	  
	  	
        Lead Director

	  
	  	  	  
	  	  	  
	  	  	  
	  	
ACCEPTED AND AGREED

	  
	  	  	  
	  	  	  
	  	  	  
	  	
 /s/ Drew A Moyer

	  
	  	
Drew A. Moyer

	  

 

10Exhibit 10.3
                                  CONFIDENTIAL

                                Supply Agreement

                               September 9th 2010

This Contract outlines the principal terms and conditions with respect to a
commercial agreement between the following parties:

Moxisign (pty) Ltd., a Company organized and incorporated in South Africa having
Registration No: 2009/020089/07 ("Moxisign"); Amol Pharmaceuticals Pvt. Ltd., a
Company organized and incorporated in India having Registration No:
U24230MH1996PTC097178 ("Amol")

The parties agree to be bound by the terms of this Contract.

Summary

Amol is a leading pharmaceutical company based in India. Amol has the ability to
supply formulated Anti Retroviral pharmaceuticals ("ARV's") as well as the
Active Pharmaceutical Ingredients in granular form (" Granular API"). Moxisign
has the desire and ability to sell ARV's and Granular API's to the South African
government's Department of Health ("DoH") by submitting a completed localized
tender submission. Moxisign has the ability to lobby their case to the relevant
stakeholders and commit to do such. Moxisign agrees to undertake to perform the
necessary Bioavailaility at their cost. The Stability testing and any other
testing expenses like Reference Standards, Columns, testing and storage charges,
ect for testing Anti-retroviral by Amol shall be shared equally between the
parties. Amol agrees to provide assistance in this process to Moxisign.

Terms of Contract

The term of this Contract shall be 36 (thirty-six) months, unless extended by
the mutual consent of all parties. Either parties may upon giving 90 (ninety)
days written notice to the other, terminate this agreement.

Conditions of Contract

     1.   Exclusive License - Amol shall grant Moxisign the exclusive license to
          offer its Anti-Retrovirals products in South Africa for a period of 30
          (thirty-six) months

     2.   Amol further agrees to:

          a.   Provide ARV's that Amol manufacture in packaged form and prodie
               patient information inserts as required by the Medicines Control
               Council of South Africa;
<PAGE>
          b.   Provide Moxisign with the necessary Dosssiers for the Drug
               registrations for ARV's with Medical Control Council of South
               Africa;

          c.   Make available any new products in the ARV range if they are
               released during the contract period subject to the approval by
               the Drug Control Authority of India;

          d.   Agree to price negotiations based on pricing of API for any drug
               and agree to provide ARV's at a fair price in order to allow
               Moxisign to fulfil its Tender requirements; the price quoted by
               Amol shall be valid for a reasonable period of 6 weeks with
               maximum upto 3 months. The price quoted will change based on any
               increase or decrease in the price ofr API's by 5%;

          e.   To use its best efforts to deliver its product as ordered and in
               the time necessary, to allow Moxisign to meet its obligations to
               the South African government as stipulated in terms of the
               Tender;

          f.   Ensure that its produc meets safety standards fro production as
               per WHO GMP.;

          g.   Ensures its product has consistent quality to meet the necessary
               MCC requirements;

     3.   Moxisign further agrees to:

          a.   Make an upfront payment of 50% by T/T along with the confirmed
               orders on a quarterly basis with supply terms to be mutually
               agreed between the parties on order to order basis and the
               balance 50% payments by at Sight Irrevocable Letter of Credit
               issued and confirmed by any Class 1 European Bank before
               shipment;

          b.   Market Amol's products for such South African government tenders
               that require ARV's by submitting a bid at Government Tenders and
               distributing through Moxisign's distribution network;

          c.   Manage the entire sales process;

          d.   Manage the entire after sales and client support process;

          e.   Make available onsite team for lobbying and government relations;

          f.   Finance its own operating costs;

          g.   Afford Amol first right of refusal to supply ARV's and Granular
               API's that Moxisign may require for sale and distribution
               throughout South Africa;

          h.   Provide Amol with adequate notice should there be any change to
               the tender requirements on account of changes in treatment for
               HIB and as dictated by South African Government; Amol would not
               hold Moxisign liable for any such change in Tender
               specifications; In such a situation.
<PAGE>
          a.   Money invested by Amol for procurement of raw materials or
               production of ARV's shall be equally shared between the parties.

4. Intellectual Property ("IP")

The IP of the individual parties shall remain the sole property of each
individual party. All Amol IP shall remain confidential. All results from
Bioavailability and Stability testing performed by Amol will be readily
available to Moxisign.

5. Any addition or deletion to this agreement shall be mutually agreed between
the parties in writing from time to time.

6. Dissolution

Upon voluntary or involuntary bankruptcy, insolvency or liquidation.

7. Dispute resolution:

Any dispute between parties relating to this agreement shall be settled as per
the Laws of Republic of India and shall have jurisdiction in India or any
International Chamber of Commerce in India.

Dr L.L Ramakrishnan                          Mrs Jyoti Kaur

Director                                     Director
/s/ Dr. L.L Ramakrishnan                     /s/ Mrs. Jyoti Kaur
-----------------------------------          -----------------------------------
For and on behalf of Moxisign                For and on behalf of Amol
(PTY) Ltd.                                   Pharmaceuticals Pvt. Ltd

Date: 9th September 2010                     Date: September 9, 2010

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00182-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00182-of-00352.parquet"}]]